Jim Vadolas

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Sickle Cell Disease

Transforming Growth Factor

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Jim Vadolas, Tiwaporn Nualkaew, Hsiao P J Voon, Shahla Vilcassim, George Grigoriadis
Interplay between α-thalassemia and β-hemoglobinopathies: Translating genotype-phenotype relationships into therapies. HemaSphere 8 (5) (2024)
Jim Vadolas, Tiwaporn Nualkaew, Hsiao P J Voon, Shahla Vilcassim, George Grigoriadis
Interplay between α-thalassemia and β-hemoglobinopathies: Translating genotype-phenotype relationships into therapies. HemaSphere 8 (5) (2024)
Sirikwan Siriworadetkun, Chayada Thiengtavor, Rattanawan Thubthed, Kittiphong Paiboonsukwong, Suthat Fucharoen, Kovit Pattanapanyasat, Jim Vadolas, Saovaros Svasti, Pornthip Chaichompoo
A comprehensive study of immune function and immunophenotyping of white blood cells from β-thalassaemia/HbE patients on hydroxyurea supports the safety of the drug. British journal of haematology (2022)
Jim Vadolas, Garrett Z Ng, Kai Kysenius, Peter J Crouch, Sibylle Dames, Mona Eisermann, Tiwaporn Nualkaew, Shahla Vilcassim, Ute Schaeper, George Grigoriadis
SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia. British journal of haematology 194 (1) (2021)